Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

One such example is SGLT2 inhibitors like Farxiga (dapagliflozin), Jardiance (empagliflozin), and Invokana (canagliflozin). These can aid in weight loss, lower the risk of cardiovascular disease, and ...

The authors explain in the study’s abstract, “Our study compared GLP-1RAs with other antidiabetics medications: insulin, metformin, alpha-glucosidase inhibitors ... Therapies at the Same Time Another ...

Investigators evaluated dipeptidyl peptidase 4 (DPP4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and SGLT2 inhibitors to determine if differences in efficacy are associated ...